Organized by generic pharmaceutical, describes the manufacturing process. Data includes the therapeutic function, chemical and common names, raw materials contained, the CAS registry, numbers, plus a world-wide list of trade names and manufacturers.

Organized by generic pharmaceutical, describes the manufacturing process. Data includes the therapeutic function, chemical and common names, raw materials contained, the CAS registry, numbers, plus a world-wide list of trade names and manufacturers.

This industry standard encyclopedia on pharmaceutical manufacturing processes has been completely updated to include FDA drugs approved up to the summer of 2004. The encyclopedia gives details for the manufacture of 2226 pharmaceuticals that are being marketed as a trade-named product somewhere in the world. Each entry includes: ò Therapeutic function ò Chemical and common name ò Structural Formula ò Chemical Abstracts Registry no. ò Trade name, manufacturer, country, and year introduced ò Raw Materials ò Manufacturing Process In addition, references are also cited under each drug's entry to major pharmaceutical works where additional information can be obtained on synthesis and the pharmacology of the individual products.

Containing the same information as the four-volume set of the updated "Pharmaceutical Manufacturing Encyclopedia," this CD-ROM database also features references cited to major pharmaceutical works where additional information can be obtained on synthesis and the pharmacology of the individual products.

An authoritative and practical guide to the art and science of formulating drugs. With thoroughly revised and expanded content, this Second Edition six-volume set compiles volumes from FDA New Drug Applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of issues concerning drug manufacturing. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this set is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent. As the largest reference on pharmaceutical formulations, this handbook also provides guidelines on how to file aNDAs in the shortest possible time, helping pharmaceutical companies to cut costs in the areas of pharmaceutical research and development. Divided conveniently into two parts—regulatory and manufacturing guidelines, and formulations—each volume in the set covers: cGMP compliance pre-approval inspections stability and bioequivalence testing packaging commodity development common difficulties in formulating drugs changes to aNDAs

This supplement to the Second Edition of the Encyclopedia of Pharmaceutical Technology heralds transformations and advances, supplying over 40 expert-authored articles as well as nearly 1900 new references to groundbreaking research studies.

Providing methodologies that can serve as a reference point for new formulations, the second volume covers uncompressed solids, which include formulations of powders, capsules, powders ready for reconstitution, and other similar products. Highlights from Uncompressed Solid Products, Volume Two include: the fundamental issues of good manufacturing practices formulations for more than 400 pharmaceutical products, including currently approved products and innovative products such as small proteins, instantly liquifiable powders, and nanoparticles access to US FDA guidelines, as well as all major guidelines around the world identification and inclusion of the most often approved capsules and powders in the US